259 related articles for article (PubMed ID: 36362040)
1. Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease.
Harrell CR; Djonov V; Volarevic V
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362040
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases.
Harrell CR; Djonov V; Antonijevic A; Volarevic V
Cells; 2023 Sep; 12(18):. PubMed ID: 37759549
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases.
Harrell CR; Volarevic V; Djonov V; Volarevic A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562878
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms Responsible for the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Lung Fibrosis.
Harrell CR; Djonov V; Volarevic A; Arsenijevic A; Volarevic V
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673961
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell-derived exosomes for managing graft-versus-host disease: An updated view.
Shafeghat Z; Dorfaki M; Dehrouyeh S; Arab FL; Roozbehani M; Falak R; Faraji F; Jafari R
Transpl Immunol; 2023 Dec; 81():101957. PubMed ID: 37935319
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure.
Harrell CR; Pavlovic D; Djonov V; Volarevic V
World J Gastroenterol; 2022 Jul; 28(28):3627-3636. PubMed ID: 36161038
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow mesenchymal stem cell-derived exosomes effectively ameliorate the outcomes of rats with acute graft-versus-host disease.
Wang Z; Wei H; Li Y; Chen W; Lin Z; Lai Y; Ding L; Zhang L; Zeng H
FASEB J; 2024 Jul; 38(13):e23751. PubMed ID: 38923701
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.
Morata-Tarifa C; Macías-Sánchez MDM; Gutiérrez-Pizarraya A; Sanchez-Pernaute R
Stem Cell Res Ther; 2020 Feb; 11(1):64. PubMed ID: 32070420
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
11. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders.
Harrell CR; Volarevic A; Djonov V; Volarevic V
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535376
[TBL] [Abstract][Full Text] [Related]
13. [Research Progress on Immunomodulatory Activity and Clinical Application of Mesenchymal Stem Cells-Derived Extracellular Vesicles--Review].
Zhao J; Jiang Y; Hao SG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):955-958. PubMed ID: 35680833
[TBL] [Abstract][Full Text] [Related]
14. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
Vanathi M; Kashyap S; Khan R; Seth T; Mishra P; Mahapatra M; Tandon R
Eur J Ophthalmol; 2014; 24(5):655-66. PubMed ID: 24604604
[TBL] [Abstract][Full Text] [Related]
15. MSCohi-O lenses for long-term retention of mesenchymal stem cells on ocular surface as a therapeutic approach for chronic ocular graft-versus-host disease.
Liu Y; Song S; Liu Y; Fu T; Guo Y; Liu R; Chen J; Lin Y; Cheng Y; Li Y; Guan T; Ling S; Zeng H
Stem Cell Reports; 2023 Dec; 18(12):2356-2369. PubMed ID: 37949071
[TBL] [Abstract][Full Text] [Related]
16. Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease.
Stenger E; Giver CR; Langston A; Kota D; Das PK; Chinnadurai R; Galipeau J; Waller EK; Qayed M
Front Immunol; 2022; 13():959658. PubMed ID: 36189324
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cell Extracellular Vesicles as a New Treatment Paradigm in Solid Abdominal Organ Transplantation: A Case Series.
Lightner AL; Fujiki M; Elshawy M; Dadgar N; Barnoski A; Osman M; Fulmer CG; Vaidya A
Stem Cells Dev; 2024 Mar; 33(5-6):107-116. PubMed ID: 38299936
[TBL] [Abstract][Full Text] [Related]
18. A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management.
Carreno-Galeano JT; Dohlman TH; Kim S; Yin J; Dana R
Ocul Immunol Inflamm; 2021 Aug; 29(6):1190-1199. PubMed ID: 34228599
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
[TBL] [Abstract][Full Text] [Related]
20. A novel study on the immunomodulatory effect of umbilical cord derived mesenchymal stem cells pretreated with traditional Chinese medicine Asarinin.
He H; Yang T; Li F; Zhang L; Ling X
Int Immunopharmacol; 2021 Nov; 100():108054. PubMed ID: 34492537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
